Senior Project Manager

Thomas has extensive scientific and biopharmaceutical leadership experience for bringing compounds through all clinical development phases from lead candidate identification to phase three and to registration and to market, resulting in two marketed products – ARZERRA® (ofatumumab) and DARZALEX® (daratumumab).

Leadership of cross-functional project teams to meet ambitious objectives and goals with high quality, within time lines and budget.

Leading the strategic and tactic preparation, implementation and execution of compound development plans including budget and resource planning.